Browse by Section 100 Item List

Highly Specialised Drugs Program (Community Access)

The Highly Specialised Drugs (HSD) Community Access arrangements align existing Section 100 HSD Program arrangements with current clinical practice and models of care, through improvements to the way some medicines are prescribed, dispensed and accessed under the s100 HSD Program. Medicines under HSD Community Access arrangements include:

  • clozapine for the treatment of schizophrenia (maintenance therapy only)
  • HIV antiretroviral medicines
  • hepatitis B medicines
  • opioid dependence medicines (see Opioid Dependence Treatment (ODT) Program)
  • lanreotide
  • octreotide.

These arrangements remove the requirement for patients and prescribers to be affiliated with a hospital setting.  Patients also have greater choice about where they access their medicines, through either a community pharmacy, or a private or public hospital pharmacy. Community pharmacists can dispense these medicines regardless of where the medicine is prescribed.

The remuneration rates for HSDs dispensed through community pharmacies are aligned to those paid to private hospitals which comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Patient eligibility criteria are unchanged. Patients will continue to pay a patient co-payment which will contribute to the PBS Safety Net Record.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 11114Y TENOFOVIR ALAFENAMIDE + EMTRICITABINE + ELVITEGRAVIR + COBICISTATtenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 2 60 5
MPNP 10310P TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 2 60 5
MPNP 11992E TENOFOVIR DISOPROXILtenofovir disoproxil fumarate 300 mg tablet, 30 2 60 2
MPNP 11142K TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 2 60 5
MPNP 11978K TENOFOVIR DISOPROXILtenofovir disoproxil phosphate 291 mg tablet, 30 2 60 2
MPNP 11155D TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 2 60 5
MPNP 11982P TENOFOVIR DISOPROXILtenofovir disoproxil maleate 300 mg tablet, 30 2 60 2
MPNP 10347N TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 12506F TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil succinate 301 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11146P TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11149T TENOFOVIR DISOPROXIL + EMTRICITABINEtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg tablet, 30 2 60 5
MPNP 11732L TENOFOVIR DISOPROXIL + EMTRICITABINE + EFAVIRENZtenofovir disoproxil maleate 300 mg + emtricitabine 200 mg + efavirenz 600 mg tablet, 30 2 60 5